Skip to main content
Clinical Trials/NCT03939806
NCT03939806UnknownNot Applicable

Renal Effects of Carbetocin and Oxytocin in Cesarean Section for Preventing Post-partum Haemorrhage: a Prospective Randomized Study

Ufuk University1 site in 1 country100 target enrollmentStarted: May 2019Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Urinary sodium

Study Overview

Brief Summary

The aim of this study is to evaluate the renal outcome of patients undergoing elective C/S where oxytocin or carbetocin is used for postpartum hemorrhage prophylaxis.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Term (>37 weeks of gestation) uncomplicated pregnant women undergoing elective cesarean section

Exclusion Criteria

  • Patients refusing to participate in the study
  • Complicated pregnancies
  • Patients with risk factors for postpartum hemorrhage
  • Contraindications for oxytocin or carbetocin usage
  • Patients with known renal diseases
  • Preterm births (<37 weeks of gestation)

Arms & Interventions

Oxytocin

This group will be given 3 IU / 3 ml oxytocin (intravenously) after the clamping of the umbilical cord. Uterine tonus will be assessed after 60 seconds and if it is lower than 7, oxytocin 3 IU / 3 ml will be repeated, up to a maximum of three times. If uterine tonus is still lower than 7, rescue uterotonics such as intramuscular methylergonovine or intravenous misoprostol will be administered.

Intervention: Oxytocin (Drug)

Carbetocin

This group will be given 100 mcg / 3 ml carbetocin (intravenously) after the clamping of the umbilical cord. If uterine tonus is lower than 7, rescue uterotonics such as intramuscular methylergonovine or intravenous misoprostol will be administered.

Intervention: Carbetocin (Drug)

Outcomes

Primary Outcomes

Urinary sodium

Time Frame: Preoperative, Postoperative 2nd, 4th, 24th hours

The change in urinary sodium content (milligrams) compared to the preoperative period

Urine volume

Time Frame: Intraoperative period

Total amount of intraoperative urine output in milliliters

Blood sodium

Time Frame: Preoperative, Postoperative 2nd, 4th, 24th hours

The change in blood sodium content (milligrams) compared to the preoperative period

Secondary Outcomes

  • Blood transfusion(Starting from the clamping of the umbilical cord, ending at the 24th postoperative hour)
  • Need for additional uterotonics(Starting from the preoperative period, ending at the 24th postoperative hour)
  • Blood osmolality(Preoperative, Postoperative 2nd, 4th, 24th hours)
  • Blood loss(Intraoperative period)

Investigators

Sponsor
Ufuk University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gamze Sinem Caglar

Clinical Professor

Ufuk University

Study Sites (1)

Loading locations...

Similar Trials